We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+10.99%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$218M
AUM Growth
-$147M
Cap. Flow
-$169M
Cap. Flow %
-77.48%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
–
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$12.8M
2
VIVO
Meridian Bioscience Inc
VIVO
+$1.78M

Top Sells

Rank Stock Value
1
CCMP
CMC Materials, Inc. Common Stock
CCMP
+$44.8M
2
KATE
Kate Spade & Company
KATE
+$24.1M
3
CIT
CIT Group Inc.
CIT
+$6.89M

Sector Composition

Rank Sector Weight
1 Healthcare 76.03%
2 Financials 23.97%
3 Consumer Discretionary 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$75M 34.47%
950,600
– –
CIT
2
DELISTED
CIT Group Inc.
CIT
$52.2M 23.97%
1,070,857
-150,000
-12% -$6.89M
ATRC icon
3
AtriCure
ATRC
$1.7B
$45M 20.67%
1,855,000
– –
CVRS
4
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$21.1M 9.69%
11,336,154
– –
ACOR
5
DELISTED
Acorda Therapeutics
ACOR
$15.2M 7%
+6,442
New +$12.8M
MGLN
6
DELISTED
Magellan Health Services, Inc.
MGLN
$7.2M 3.31%
98,700
– –
VIVO
7
DELISTED
Meridian Bioscience Inc
VIVO
$1.94M 0.89%
+123,300
New +$1.78M
SPY icon
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$786B
– –
-244,000
Closed -$57.5M
CCMP
9
CALL
DELISTED
CMC Materials, Inc. Common Stock
CCMP
– –
-649,000
Closed -$49.7M
CCMP
10
DELISTED
CMC Materials, Inc. Common Stock
CCMP
– –
-585,300
Closed -$44.8M
KATE
11
DELISTED
Kate Spade & Company
KATE
– –
-1,039,000
Closed -$24.1M

Similar funds

SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FWM
Fingerlakes Wealth Management Ithaca, New York $151M AUM 20.78% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $151M AUM 14.38% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return

Hudson Executive Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Hudson Executive Capital held 11 positions worth $218M, down 40% from $365M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital withdrew a net $169M in Q2 2017, closing 4 positions and reducing 1 holding. Its most notable exit was CMC Materials, Inc. Common Stock, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 37% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Hudson Executive Capital opened a new position in Acorda Therapeutics worth $15.2M.

  • Hudson Executive Capital's largest Q2 2017 buy was Acorda Therapeutics: 6,442 shares worth $15.2M.
  • Hudson Executive Capital's biggest Q2 2017 reduction was CIT Group Inc., cutting an estimated $6.89M.
  • Hudson Executive Capital fully exited CMC Materials, Inc. Common Stock in Q2 2017, selling an estimated $44.8M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $218M portfolio in Q2 2017.
  • Hudson Executive Capital opened 2 new positions and closed 4 in Q2 2017.
  • Hudson Executive Capital's portfolio value fell 40% quarter-over-quarter to $218M.

Based on Hudson Executive Capital's 13F filing for Q2 2017, filed 14 Aug 2017.